Acute toxicity of an anti-Fas antibody in mice

C Kakinuma1, K Takagaki, T Yatomi

  • 1Toxicology Laboratory, Mochida Pharmaceutical Co., Ltd., Fujieda, Shizuoka, Japan.

Toxicologic Pathology
|September 15, 1999
PubMed

Insights

Anti-Fas antibody (Jo2) causes acute lethality in mice, primarily through liver injury. Susceptibility varies among mouse strains, with C3H/HeN being most vulnerable to Fas-mediated apoptosis.

Area of Science:

  • Immunology
  • Toxicology
  • Pathology

Background:

  • The Fas/anti-Fas antibody interaction is known to induce apoptosis.
  • Understanding the specific organ targets and strain-dependent susceptibility is crucial for assessing toxicity.

Purpose of the Study:

  • To investigate the target organs responsible for acute lethality induced by anti-Fas antibody (Jo2) in mice.
  • To evaluate differences in susceptibility to anti-Fas antibody among normal mouse strains.
  • To characterize the pattern of Fas-mediated apoptosis across various organs.

Main Methods:

  • Histopathologic examination of multiple organs in C3H/HeN, ICR, and DBA/1J mice.
  • Intravenous administration of anti-Fas antibody (Jo2).
  • Assessment of Fas-mediated apoptosis in different tissues.

Main Results:

  • Liver injury was identified as the primary cause of acute lethality.
  • Fas-mediated apoptosis was observed in numerous organs beyond the liver, including spleen, thymus, lymph nodes, and intestines.
  • Significant differences in susceptibility to anti-Fas antibody were noted, with C3H/HeN mice being most susceptible, followed by ICR and DBA/1J mice.
  • Apoptosis in splenic lymphocytes preceded that in hepatocytes or thymic cells.

Conclusions:

  • Anti-Fas antibody-induced liver injury plays a significant role in acute lethality.
  • Mouse strain differences influence susceptibility to anti-Fas antibody-mediated toxicity.
  • Fas-mediated apoptosis occurs broadly across multiple organs, not exclusively in the liver.

Related Concept Videos